Poly Medicure (BOM:531768) Interest Expense: ₹-218 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531768 Poly Medicure Ltd BOM:531768
95 GF Score
Price ₹1,772.85
GF Value ₹2,391.70
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Poly Medicure Interest Expense?

Poly Medicure BOM:531768 +4.76% 95 Interest Expense is ₹-218 Mil as of Jun. 2026. GuruFocus rates BOM:531768 with a GF Score™ of 95/100 and a GF Value™ of ₹2,391.70 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Poly Medicure's interest expense for the three months ended in Jun. 2026 was ₹ -65 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-218 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Poly Medicure's Operating Income for the three months ended in Jun. 2026 was ₹ 888 Mil. Poly Medicure's Interest Expense for the three months ended in Jun. 2026 was ₹ -65 Mil. Poly Medicure's Interest Coverage for the quarter that ended in Jun. 2026 was 13.67. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poly Medicure  (BOM:531768) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poly Medicure's Interest Expense for the three months ended in Jun. 2026 was ₹-65 Mil. Its Operating Income for the three months ended in Jun. 2026 was ₹888 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was ₹0 Mil.

Poly Medicure's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*888.448/-65.014
=13.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Poly Medicure Interest Expense Historical Data

* Premium members only.

The historical data trend for Poly Medicure's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poly Medicure Interest Expense Chart

Poly Medicure Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.24 -85.43 -106.97 -119.97 -182.91

Poly Medicure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.50 -29.73 -59.59 -64.09 -65.01
BOM:531768
95GF Score
Poly Medicure Ltd BOM:531768
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poly Medicure Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-218 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-218 Mil mean?
Poly Medicure (BOM:531768) has a Interest Expense of ₹-218 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Poly Medicure and its competitors.
Is Poly Medicure's Interest Expense too high?
Poly Medicure's current Interest Expense is ₹-218 Mil. Overall, Poly Medicure has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Interest Expense compare to ISRG and BDX?
Poly Medicure's Interest Expense of ₹-218 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Poly Medicure and its competitors. Poly Medicure's current Interest Expense is ₹-218 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (BOM:531768) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,391.70, compared to a current price of ₹1,772.85 — trading 25.9% below its estimated fair value. The current Interest Expense is ₹-218 Mil. Poly Medicure's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Poly Medicure (BOM:531768), the current Interest Expense is ₹-218 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Poly Medicure (BOM:531768) Overvalued in 2026?

Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued. The current stock price of ₹1,772.85 is trading 25.9% below its estimated GF Value™ of ₹2,391.70. GuruFocus considers Poly Medicure to be Modestly Undervalued.

Key valuation signals for BOM:531768:

  • Interest Expense: ₹-218 Mil
  • GF Value™: ₹2,391.70 vs. price of ₹1,772.85 (25.9% below fair value)
  • GF Score™: 95/100 with 7 warning signs

No single metric tells the full story. See the BOM:531768 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poly Medicure Business Description

Other Exchanges POLYMED:India
Address Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
95GF Score

Get the complete analysis for BOM:531768

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,772.85
Price
₹2,391.70
GF Value